AGIOS PHARMACEUTICALS, INC. Insider Trading for September 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for September 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 23.10 | 856 | 19,774 | 88,242 | |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 85.97 | 6,000 | 515,820 | 0 | 6 K to 0 (-100.00 %) |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 23.10 | 856 | 19,774 | 6,000 | 5.1 K to 6 K (+16.64 %) |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Payment of Exercise | F | 88.89 | 4,856 | 431,650 | 5,144 | 10 K to 5.1 K (-48.56 %) |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 82.07 | 2,426 | 199,102 | 147,854 | 150.3 K to 147.9 K (-1.61 %) |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 82.09 | 2,426 | 199,150 | 147,854 | 150.3 K to 147.9 K (-1.61 %) |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 84.42 | 2,426 | 204,803 | 150,280 | 152.7 K to 150.3 K (-1.59 %) |
Sep 28 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 84.43 | 2,426 | 204,827 | 150,280 | 152.7 K to 150.3 K (-1.59 %) |
Sep 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 17,520 | 5,300 | 255,022 | |
Sep 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 2,480 | 750 | 272,542 | |
Sep 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 91.11 | 20,000 | 1,822,200 | 141,835 | 161.8 K to 141.8 K (-12.36 %) |
Sep 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 17,520 | 5,300 | 161,835 | 144.3 K to 161.8 K (+12.14 %) |
Sep 17 2015 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 2,480 | 750 | 144,315 | 141.8 K to 144.3 K (+1.75 %) |